Detalles de la búsqueda
1.
Towards understanding how bisphosphonate-dependent alterations to nutrient canal integrity can contribute to risk for atypical femoral fractures: Biomechanical considerations and potential relationship to a real-world analogy.
Bioessays
; 46(2): e2300117, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38059881
2.
Are secondary effects of bisphosphonates on the vascular system of bone contributing to increased risk for atypical femoral fractures in osteoporosis?
Bioessays
; 45(4): e2200206, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36807308
3.
Risk of fractures and use of bisphosphonates in adult patients with immune thrombocytopenia-A nationwide population-based study.
Br J Haematol
; 204(4): 1464-1475, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38302094
4.
Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget's disease of bone.
Ann Rheum Dis
; 83(4): 529-536, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123339
5.
Deprescribing bisphosphonates for older adults with dementia: perspectives of caregivers.
Osteoporos Int
; 35(4): 589-598, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37980284
6.
Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study.
Osteoporos Int
; 35(4): 669-678, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38195713
7.
Postoperative Bisphosphonates Use is Associated with Reduced Adverse Outcomes After Primary Total Joint Arthroplasty of Hip and Knee: A Nationwide Population-Based Cohort Study.
Calcif Tissue Int
; 114(5): 451-460, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38492035
8.
Safety and effectiveness of risedronate in Paget's disease of bone: postmarketing surveillance study in Japan.
J Bone Miner Metab
; 42(1): 122-133, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38197974
9.
Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effects.
Support Care Cancer
; 32(3): 202, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38427111
10.
Pamidronate-induced irreversible symptomatic hypocalcemia in a dog with hypercalcemia after glucocorticoid withdrawal: a case report.
BMC Vet Res
; 20(1): 227, 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38790012
11.
Recognizing bisphosphonate-induced ear osteonecrosis in primary care: a case report.
Fam Pract
; 41(2): 219-222, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38413046
12.
Increased risk of hypocalcemia with decreased kidney function in patients prescribed bisphosphonates based on real-world data from the MID-NET® in Japan: a new-user cohort study.
BMC Nephrol
; 25(1): 134, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38622507
13.
Bisphosphonate treatment for skeletal complications in paediatric cancer-Experience from a single tertiary centre.
Acta Paediatr
; 113(6): 1446-1452, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38329165
14.
The trend of dental check-up and prevalence of dental complications following the use of bone modifying agents in patients with metastatic breast and prostate cancer: analysis of data from the Korean National Health Insurance Service.
BMC Health Serv Res
; 24(1): 412, 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38566103
15.
Patient preference, efficacy, and compliance with zoledronic acid for glucocorticoid-induced osteoporosis in patients with autoimmune diseases.
Postgrad Med J
; 100(1183): 334-341, 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38297995
16.
Nanoanalytical analysis of bisphosphonate-driven alterations of microcalcifications using a 3D hydrogel system and in vivo mouse model.
Proc Natl Acad Sci U S A
; 118(14)2021 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33795519
17.
Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians.
Ann Intern Med
; 176(2): 224-238, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36592456
18.
Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.
Ann Intern Med
; 176(2): 182-195, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36592455
19.
No increased risk of osteonecrosis of the jaw in osteoporotic patients with dental implants: a nationwide cohort study.
Clin Oral Investig
; 28(1): 83, 2024 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38195947
20.
Bisphosphonate Use May be Associated With an Increased Risk of Periprosthetic Hip Fracture.
J Arthroplasty
; 39(2): 448-451.e1, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37586595